Kiniksa Pharmaceuticals International, plc
Equities
KNSA
GB00BRXB0C07
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.1 USD | +3.52% | +3.08% | +8.89% |
07-01 | Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf | MT |
07-01 | Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 2500 Growth Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.89% | 1.31B | |
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals International, plc
- Sector Update: Health Care Stocks Steady in Late Afternoon Trading